Is CBD legal in Turkey?

Legal status

CBD is absent from Turkey's closed narcotics list. The dossier ran a completed list search, «Arama kaydı: “cbd” adı, yaygın eş anlamlıları ve kimyasal adı 2313 sayılı Kanun kapsamındaki kararların tamamında arandı; tam kayıt bulunmadı.», the name, common synonyms and chemical name were searched across all the decisions made under Law No. 2313 and no exact entry was found. That verified absence means the narcotics schedule does not reach cannabidiol as a molecule, and it says nothing about unrestricted legality under other law. The other law here is substantial and specific. Article 3 of Law No. 2313 prohibits the preparation, import, export and sale of esrar in whatever form, and article 23 as amended by Law No. 7557 of 21 July 2025 subjects hemp growing for medicinal, health and personal care products to Ministry of Agriculture and Forestry permission, places licensing and registration of the resulting products with the Ministry of Health, and provides «Bu ürünler sadece eczanelerden satılabilir», these products may be sold only in pharmacies. So the molecule is unscheduled and the plant and the finished product are not unregulated.

Consequences if caught

Capital exposure: none. No controlled drug capital, life or quantity rule attaches to cannabidiol itself, because the substance is absent from the closed narcotics list; separate regulatory law may still apply. Articles 188 and 191 of Penal Code No. 5237 therefore do not engage on the molecule, and neither the thirty year ceiling in 188(1) nor the two to five year use offence in 191(1) is in play for CBD as such. The exposure that does exist runs through what a product contains and how it was made rather than through CBD: a preparation found to contain a scheduled cannabinoid is charged on that substance, cultivation without permission is prohibited by article 23 of Law No. 2313 whatever the intended purpose, and cultivation to obtain esrar carries four to twelve years under the same article. The content of a product is settled by the analysis required under article 20 of Law No. 2313, not by the label percentage.

If prescribed or medical

Cannabis derived medicinal products have a lawful Turkish route and it is a pharmacy route. Article 23 of Law No. 2313 as amended in 2025 gives the Ministry of Health the licensing and registration of medicinal, health and personal care products obtained from hemp and confines their sale to pharmacies, with the procedures to be set by regulation made after consulting the interior and agriculture ministries. The dossier carried no prescription instrument for this row and made no finding on which CBD products hold a Turkish authorisation, so that question is for the TİTCK and is deferred here. A foreign prescription, and a foreign food supplement label, are neither of them Turkish authorisations.

Documentation

Do not treat an unscheduled molecule as a cleared product. A CBD oil, vape liquid or supplement bought abroad is an unanalysed cannabis derived preparation at a Turkish border, and the questions that will be asked concern its total cannabinoid content and its authorisation, neither of which a retail label answers. If a Turkish authorised product exists for the condition being treated, obtain it through a pharmacy in country; if travelling with a prescribed cannabis derived medicine, carry the original dispensing packaging with the prescription and a prescriber's letter and settle it with the TİTCK in advance. The verified absence was read in the dossier on 18 September 2026 and articles 3, 20 and 23 were read from the consolidated statute on 20 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Turkey’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.